Other cystic kidney diseases
ICD-10 Q61.8 is a billable code used to indicate a diagnosis of other cystic kidney diseases.
Q61.8 refers to other cystic kidney diseases that are congenital in nature, which may include conditions such as renal agenesis, polycystic kidney disease, and other less common cystic renal anomalies. Renal agenesis is characterized by the absence of one or both kidneys, leading to significant implications for renal function and overall health. Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys, which can lead to renal failure and other complications. Other cystic kidney diseases may include conditions like nephronophthisis and medullary cystic kidney disease, which can also affect renal function. These congenital malformations often require multidisciplinary management, including pediatric nephrology, urology, and genetics, to address the complex needs of affected children. Accurate coding is essential for appropriate treatment planning and resource allocation.
Detailed pediatric history, including prenatal and perinatal factors, growth and development assessments, and any associated congenital anomalies.
Management of a newborn with renal agenesis, follow-up for a child diagnosed with polycystic kidney disease, and evaluation of urinary tract anomalies.
Consideration of growth parameters and developmental milestones in pediatric patients, as well as the psychosocial impact on families.
Genetic testing results, family history of renal diseases, and any syndromic associations.
Genetic counseling for families with a history of polycystic kidney disease, evaluation of syndromic conditions associated with renal anomalies.
Understanding the inheritance patterns and implications for family members, as well as the need for potential prenatal testing.
Used for patients with end-stage renal disease due to congenital anomalies.
Detailed medical history, indication for transplant, and pre-operative evaluations.
Pediatric nephrology considerations for donor and recipient matching.
Documentation should include a clear diagnosis of the specific cystic kidney disease, any associated congenital anomalies, imaging studies, and genetic testing results when applicable. Detailed clinical notes that outline the patient's history and management plan are also essential.
